Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancy

Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

166 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancy trial results

Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

NCT06462365

Conditions
Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, Adult T-Cell, Acute Myeloid Leukemia in Remission, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions
ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Children's Hospital Colorado Denver, Colorado, United States
View all 31 locations
View Trial Details

Related conditions